Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development

Area of Science:

• Oncology
• Immunology

Background:

• Immunotherapy has transformed cancer treatment but shows limited durable responses in gastric cancer (GC).
• The complex tumor microenvironment (TME) in GC promotes immune evasion and resistance to therapies.
• Specific TME components contribute to immune escape through cancer-specific mechanisms.

Purpose of the Study:

• To review recent advances in understanding the GC TME.
• To explore the role of the immunosuppressive TME in determining treatment response.
• To identify potential therapeutic strategies beyond current checkpoint inhibition.

Main Methods:

• Literature review of recent studies on GC TME.
• Analysis of molecular mechanisms driving immune evasion in GC.
• Synthesis of current knowledge on TME components and their impact on immunotherapy.

Main Results:

• The heterogeneous GC TME is a significant barrier to effective immunotherapy.
• Specific molecular factors within the TME enable immune escape.
• The immunosuppressive TME acts as a context-specific determinant of treatment efficacy.

Conclusions:

• Targeting the immunosuppressive TME is crucial for enhancing immunotherapy in GC.
• Understanding molecular mechanisms of immune evasion can guide novel treatment strategies.
• Future therapies may involve approaches beyond conventional checkpoint inhibitors for GC.